Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
David J Kopsky, Karolina M Szadek, Patrick Schober, Alexander F J E Vrancken & Monique A H Steegers. (2022) Study Design Characteristics and Endpoints for Enriched Enrollment Randomized Withdrawal Trials for Chronic Pain Patients: A Systematic Review. Journal of Pain Research 15, pages 479-496.
Read now
Read now
Filippo Migliorini, Nicola Maffulli, Jörg Eschweiler, Matthias Knobe, Markus Tingart & Giorgia Colarossi. (2022) Pharmacological management of fibromyalgia: a Bayesian network meta-analysis. Expert Review of Clinical Pharmacology 15:2, pages 205-214.
Read now
Read now
Filippo Migliorini, Nicola Maffulli, Jörg Eschweiler, Markus Tingart, Arne Driessen & Giorgia Colarossi. (2021) BMI but not age and sex negatively impact on the outcome of pharmacotherapy in fibromyalgia: a systematic review. Expert Review of Clinical Pharmacology 14:8, pages 1029-1038.
Read now
Read now
Alessandra Morano, Caterina Palleria, Rita Citraro, Valentina Nesci, Carmen De Caro, Anna Teresa Giallonardo, Giovambattista De Sarro, Emilio Russo & Carlo Di Bonaventura. (2019) Immediate and controlled-release pregabalin for the treatment of epilepsy. Expert Review of Neurotherapeutics 19:12, pages 1167-1177.
Read now
Read now
Alessandra Alciati, Fabiola Atzeni, Ignazio Francesco Masala, Mariateresa Cirillo, Davide Sciortino, Giampaolo Perna & Piercarlo Sarzi-Puttini. (2018) Controlled-release pregabalin in the treatment of fibromyalgia. Expert Review of Neurotherapeutics 18:8, pages 617-623.
Read now
Read now
Lesley M. Arnold, Ernest Choy, Daniel J. Clauw, Hiroshi Oka, Ed Whalen, David Semel, Lynne Pauer & Lloyd Knapp. (2018) An evidence-based review of pregabalin for the treatment of fibromyalgia. Current Medical Research and Opinion 34:8, pages 1397-1409.
Read now
Read now
Fabiola Atzeni, Maria Chiara Gerardi, Ignazio Francesco Masala, Alessandra Alciati, Alberto Batticciotto & Piercarlo Sarzi-Puttini. (2017) An update on emerging drugs for fibromyalgia treatment. Expert Opinion on Emerging Drugs 22:4, pages 357-367.
Read now
Read now
Maria Chiara Gerardi, Fabiola Atzeni, Alberto Batticciotto, Manuela Di Franco, Maurizio Rizzi & Piercarlo Sarzi-Puttini. (2016) The safety of pregabalin in the treatment of fibromyalgia. Expert Opinion on Drug Safety 15:11, pages 1541-1548.
Read now
Read now
Maria Chiara Gerardi, Alberto Batticciotto, Rossella Talotta, Manuela Di Franco, Fabiola Atzeni & Piercarlo Sarzi-Puttini. (2016) Novel pharmaceutical options for treating fibromyalgia. Expert Review of Clinical Pharmacology 9:4, pages 559-565.
Read now
Read now
Articles from other publishers (10)
Filippo Migliorini, Nicola Maffulli, Matthias Knobe, Giacomo Tenze, Ali Aljalloud & Giorgia Colarossi. (2022) Pregabalin administration in patients with fibromyalgia: a Bayesian network meta-analysis. Scientific Reports 12:1.
Crossref
Crossref
Filippo Migliorini, Nicola Maffulli, Jörg Eschweiler, Marcel Betsch, Markus Tingart & Giorgia Colarossi. (2021) Placebo effect in pharmacological management of fibromyalgia: a meta-analysis. British Medical Bulletin 139:1, pages 73-85.
Crossref
Crossref
Suzanne Nielsen, Natasa Gisev, Janni Leung, Philip Clare, Raimondo Bruno, Nicholas Lintzeris, Briony Larance, Fiona Blyth, Wayne Hall, Milton Cohen, Louisa Degenhardt, Michael Farrell & Gabrielle Campbell. (2021) Clinical correlates and outcomes associated with pregabalin use among people prescribed opioids for chronic non‐cancer pain: A five‐year prospective cohort study. British Journal of Clinical Pharmacology 87:8, pages 3092-3104.
Crossref
Crossref
Jörn Lötsch, Carmen Walter, Martin Zunftmeister, Sebastian Zinn, Miriam Wolters, Nerea Ferreiros, Tanja Rossmanith, Bruno G. Oertel & Gerd Geisslinger. (2019) A data science approach to the selection of most informative readouts of the human intradermal capsaicin pain model to assess pregabalin effects. Basic & Clinical Pharmacology & Toxicology 126:4, pages 318-331.
Crossref
Crossref
Marci Chew, Guangli Ma, Rujia Xie, Howard Bockbrader, Sunny Chapel & Scott Marshall. (2019) Population Pharmacokinetics of Pregabalin Extended‐Release in Healthy Volunteers and Patients With Postherpetic Neuralgia, Fibromyalgia, and Partial‐Onset Seizures. The Journal of Clinical Pharmacology 59:11, pages 1527-1542.
Crossref
Crossref
Cynthia L. Huffman, James N. Goldenberg, James Weintraub, Luis Sanin, Joseph Driscoll, Ruoyong Yang, Marci L. Chew & Joseph M. Scavone. (2017) Efficacy and Safety of Once-Daily Controlled-Release Pregabalin for the Treatment of Patients With Postherpetic Neuralgia. The Clinical Journal of Pain 33:7, pages 569-578.
Crossref
Crossref
Elena P Calandre, Fernando Rico-Villademoros & Mahmoud Slim. (2017) Pharmacological treatment of fibromyalgia: is the glass half empty or half full?. Pain Management 7:1, pages 5-10.
Crossref
Crossref
Sheena Derry, Malene Cording, Philip J Wiffen, Simon Law, Tudor Phillips & R Andrew Moore. (2016) Pregabalin for pain in fibromyalgia in adults. Cochrane Database of Systematic Reviews 2019:5.
Crossref
Crossref
Ole Schjerning, Mary Rosenzweig, Anton Pottegård, Per Damkier & Jimmi Nielsen. (2016) Abuse Potential of Pregabalin. CNS Drugs 30:1, pages 9-25.
Crossref
Crossref
Marci L. Chew, Anna Plotka, Christine W. Alvey, Verne W. Pitman, Tanja Alebic-Kolbah, Joseph M. Scavone & Howard N. Bockbrader. (2015) Effect of the Gastrointestinal Prokinetic Agent Erythromycin on the Pharmacokinetics of Pregabalin Controlled-Release in Healthy Individuals: A Phase I, Randomized Crossover Trial. Clinical Drug Investigation 35:5, pages 299-305.
Crossref
Crossref